Skip to main content

Combined Neuroprotection/Thrombolysis in Acute Stroke

  • Chapter
Stroke

Part of the book series: Update in Intensive Care and Emergency Medicine ((UICM,volume 27))

  • 183 Accesses

Abstract

The major barrier to effective use of thrombolytic therapy in acute stroke remains the fact that most patients have irreversible damage before it is possible to treat them with these new agents. As discussed elsewhere in this volume, major efforts are being made to bring patients in for treatment earlier in the stroke process. Another approach is to find ways to protect vulnerable brain tissue from ischemic damage long enough to permit the use of thrombolytic therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Zivin JA, deGirolami U, Kochhar A, et al (1987) A model for quantitative evaluation of embolic stroke therapy. Brain Res 435:305–309

    Article  PubMed  CAS  Google Scholar 

  2. Zivin JA, Mazzarella V (1991) Tissue plasminogen activator plus glutamate antagonist improves outcome after embolic stroke. Arch Neurol 48:1235–1238

    PubMed  CAS  Google Scholar 

  3. Bowes MP, Rothlein R, Fagan SC, et al (1995) Monoclonal antibodies preventing leukocyte activation reduce experimental neurologic injury and enhance efficacy of thrombolytic therapy. Neurology 45:815–819

    PubMed  CAS  Google Scholar 

  4. Uematsu D, Araki N, Greenberg JH, et al (1991) Combined therapy with MK-801 and nimo- dipine for protection of ischemic brain damage [see comments]. Neurology 41 (1):88–94

    PubMed  CAS  Google Scholar 

  5. Aronowski J, Strong R, Grotta JC:Combined neuroprotection and reperfusion therapy for stroke:the effect of lubeluzole and diaspirin crosslinked hemoglobin in experimental focal ischemia. Stroke 27:1571–1576

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Zivin, J., Grotta, J. (1998). Combined Neuroprotection/Thrombolysis in Acute Stroke. In: Steiner, T., Hacke, W., Hanley, D.F. (eds) Stroke. Update in Intensive Care and Emergency Medicine, vol 27. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60264-1_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-60264-1_11

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-64326-2

  • Online ISBN: 978-3-642-60264-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics